inVentiv Communications Inc.

Vince Parry is responsible for developing and leading a broad range of agency and communications capabilities in New York. He is also the founder and leader of Y Brand, inVentiv Communications strategic branding group. Headquartered in Manhattan, this group offers branding strategy development, consensus-building brand behavior models, proprietary branding research, and branding hallmark design. Since joining inChord in November 2001, he has conducted branding initiatives for clients such as: Lilly (Zyprexa global franchise, oncology portfolio, Xigris), Abbott (Biaxin), Roche (corporate, Fortovase), Genentech (Rituxan, Raptiva), AstraZeneca (Pulmicort), Corporate One (corporate), and Emisphere (corporate). With expertise in creative services, branding and global new product planning, Mr. Parry previously served as executive vice president/Chief Creative Officer at Sudler & Hennessey for 13 years, where he created and led Signature, S&H's brand identity group. He also developed the agency's creative protocols and directed the integration of creative activity between all lines of S&H business on a global basis, as well as cross-servicing opportunities with parent company Young & Rubicam. His global branding experience includes Lipitor, Vioxx, Rocephin, Neupogen, Amevive, Xenical, Nolvadex, Tamiflu, Propecia, Nicotrol, Accolate, Effexor, Advil, Benadryl, Sudafed, Dove, Colgate and Sony. Before S&H, Mr. Parry served as Group Creative Director at Klemtner Advertising, leading the work on Wyeth, Procter & Gamble and Berlex, among other accounts.

As CMO for GSW Worldwide, Brian Heffernan is responsible for providing global and strategic marketing leadership with a focus on consumer and DTC efforts. He also leads the agency's health and well-being practice, helping marketers capitalize upon consumers' growing interest and involvement in health and well-being. Mr. Heffernan brings over 20 years of national and international consumer advertising experience. He has worked on many high-profile assignments for global marketers such as Nestle, Blockbuster, Kraft, Nabisco and Miller. Mr. Heffernan worked at J. Walter Thompson's (JWT) New York office. In 1997 he helped JWT make its initial transition from consumer agency to work in healthcare and DTC. He then went on to become president of JWT's Chicago office before joining GSW Worldwide.

Array

Guy Mastrion has over 25 years of strategic and creative expertise across a wide range of advertising communications. From local to national and international advertising campaigns, from post cards to television, radio, internet, his unique combination of talents and creativity continue to be a driving force for Palio and their clients. Everyday at Palio he oversees the conception and execution of their work alongside his team of senior creative directors. Prior to joining Palio he was EVP managing director/creative director of Lowe McAdams NY where he specialized in the development and execution of all consumer television and direct marketing efforts. He has held executive level positions in some of the worlds' largest advertising agencies, including Bates, Saatchi and Saatchi and McCann Erickson. Mr. Mastrion received his Bachelor of Fine Arts degree from the Parsons School of Design.

Tyrone Brewer, COO of inVentiv Patient Outcomes, is responsible for assisting in strategic planning, financial planning and forecasting; identifying investment/growth opportunities, new opportunities, new or emerging services and new companies for the Patient Outcomes Group. Before joining inVentiv Patient Outcomes, Mr. Brewer provided key leadership at The Franklin Group, most recently in the role of Executive Director of Marketing and Business Development. With more than 15 years of industry experience, Mr. Brewer's prior positions include Product Director for PROCRIT at Ortho Biotech where he led the building and execution of the strategic business plan for the Nephrology franchise. He was the Senior Global Marketing Director for Anti-infectives at Aventis Pharmaceuticals where he led the worldwide development and implementation of the global leadership marketing strategy, global product positioning, pricing strategies, brand development and communication strategies. Mr. Brewer has also held a variety of roles in sales, training, sales management and marketing. He holds B.A. from the College of New Jersey.

Stephen Cottrell brings almost 20 years of industry experience to inVentiv Clinical Solutions. In his role as Executive Vice President of Operations and Business Development, he is responsible for leading marketing and business development efforts for all clinical divisions to drive revenue growth for the company. Prior to rejoining the inVentiv family, Mr. Cottrell served as Executive Vice President and then President of AAI Development Services, where he led a midsized CRO providing services from late-stage discovery through Phase IV to North America, Western Europe, and Japan. He also served as Executive Vice President of EduNeering Holdings, Inc., where he led the sales and marketing efforts for a small venture-funded company providing online training services focused on clinical development within the pharmaceutical and health insurance industries. Mr. Cottrell holds a B.S. in Economics from Boston University.

Brad Patten is Senior Vice President of Business Development, inVentiv Commercial, which includes the Selling Solutions and Strategy and Analytics divisions. Mr. Patten joined inVentiv in 1998 and has provided great leadership to the organization in various roles, including National Business Director, Director of Sales Training and Management Development, Sr. Director of Recruiting Services and Operations, Executive Director of Managed Markets and Business Development, and Vice President, Marketing and Corporate Business Development. Mr. Patten brings additional expertise in the areas of marketing, having functioned as Vice President of Oncology Marketing for Zeneca, where he was responsible for all aspects of the strategic planning, promotion, and management of a diversified oncology portfolio. His product commercialization experience and in-depth knowledge of the clinical and regulatory processes have been essential to the successful launch of multiple products by the Ventiv Sales and Marketing Teams on behalf of their client-partners. Mr. Patten has also held several senior sales leaderships positions with Zeneca, as well as with Stuart Pharmaceuticals and ICI Pharma. His career in the pharmaceutical industry has spanned the therapeutic areas of cardiology, oncology, CNS, anti-infectives, gastroenterology, anesthesiology and pain management. He attended Upsala College in New Jersey, where he earned a B.S. in Biology and a minor in Chemistry.

Kristopher Coombs leads inVentiv Communications' HR department and oversees all related functions including staffing, compensation, benefits, training, organizational development and talent management for all 13 of inVentiv Communications' companies. Coombs joined inVentiv from Kao Brands, a $1 billion global consumer products company that markets brands such as Jergens, Curel, Biore and John Frieda. He was a member of Kao's HR team (formerly Andrew Jergens Company) for more than 10 years, most recently as vice president of human resources and administration. While there, Coombs led the company's talent management program, managed integration efforts of mergers and acquisitions, led organizational restructuring and developed and implemented strategic HR processes. Prior to Kao, he spent eight years in management roles at Employers Resource Association, a non-profit organization providing training and HR consulting to member companies. Coombs holds a bachelor's degree in business administration from Xavier University.

Ms. Jennings earned a B.A. from North Central College in Naperville, Illinois. She has also successfully completed the Strategic Sale Management Program at The University of Chicago Graduate School of Business. Ms. Jennings remains an active member of the Healthcare Business Women's Association, as well as several community organizations.

As Senior Vice President and Managing Director of Ventiv Recruitment Services, Mr. Vogel leads the Ventiv Recruitment Team of experts in the development of customized staffing solutions that deliver "on profile and on time" professionals committed to overachieving our customers expectations. Mr. Vogel has 26 years of pharmaceuticals sales, marketing and sales operations experience. Before joining inVentiv he served as Vice President of Sales and Sales Operations at NPS Pharmaceuticals. Mr. Vogel began his Pharmaceutical career as a sales representative at Searle Pharmaceuticals. Before joining NPS, Mr. Vogel was at Sanofi-Aventis where he held a variety of responsibilities including VP of Metabolism Sales, VP Respiratory Sales and VP Business Performance Improvement. Mr. Vogel earned his B.S. degree at Ball State University and MBA at Lake Forest School of Management and holds a Black Belt in Lean Six Sigma methodologies.

Bryan Horveath is the Senior Vice President and Managing Director for the Ventiv Professional Development Group. Mr. Horveath leads a team of training professionals that design, develop and deliver quality training and development services. Prior to his promotion, Mr. Horveath ran Client Training and Development, where he was responsible for overseeing the management and representative training function for several inVentiv contracts. Mr. Horveath brings more than 14 years of experience in the pharmaceutical industry in the areas of training and development, performance improvement, business development, sales management and marketing on both the client and vendor sides of the business. His diverse sales, marketing and training experience covers a wide range of therapeutic classes, including cardiology, CNS, endocrinology, gastroenterology, pain management and women's health. Mr. Horveath received his B.S. degree in Microbiology from the Pennsylvania State University, and he will be recognized in the 2006-2007 edition of the National Register's Who's Who in Executives and Professionals. He is also a member of the American Society for Training & Development, International Society for Performance Improvement and the Society of Pharmaceutical & Biotech Trainers.

As Senior Vice President and Managing Director of The Franklin Group, John Doster is responsible for the oversight, positioning and growth of the company including: patient assistance programs, reimbursement services, Medicare patient services programs, transitional patient care/pharmacy and distribution services. With more than 15 years in the biopharmaceutical industry, Mr. Doster has substantial experience in sales leadership, operations, distribution, managed markets and brand marketing. His areas of expertise include program development and execution for enhanced patient access to medications. He has designed and successfully implemented strategic support initiatives in a variety of therapeutic areas including oncology, cardiovascular, injectable products, biotech, and managed markets. Before joining the inVentiv team, Mr. Doster worked at Aventis Pharmaceuticals where he specialized in antibiotic, respiratory and cardiovascular products. His keen leadership and strategic skills enabled him to hold various senior sales, marketing and management positions such as Director, Sales and Marketing Services and Head, Allegra Marketing, leading the marketing efforts for the flagship brand in the Respiratory Products Division. Mr. Doster holds a B.S. from Union University.

Mark Frank serves as EVP/Managing Director over GSW Worldwide's Newtown, Pennsylvania office, which opened in 2006. Prior to leading the establishment of that office, he worked for eight years at GSW Worldwide's Columbus office, where he held positions of increasing levels of responsibility, managing accounts for Zyprexa, Prevacid, Cymbalta, Topamax, Strattera, Lupron and CIGNA Healthcare. Prior to joining GSW Worldwide in 1998, Mr. Frank served as Marketing Director for Novartis Pharmaceuticals where he was responsible for several brands in therapeutic categories including neuroscience, cardiovascular, gastrointestinal and immunology. Mr. Frank also served as a consultant with Corporate Health Strategies before working at Novartis. Additional accounts that he has worked on include Sears, Alcoa, General Motors and LTV Steel Corp. Mr. Frank holds a bachelor's and master's degree from the University of Massachusetts.

Warren Merlino is the Executive Vice President and Managing Director Logistic Services of PROMOTECH. At PROMOTECH, Warren oversees a full suite of non- personal promotion services for the life sciences industry to include fulfillment, distribution, warehousing, direct mail, database management, tele-services, e-services, print center and direct mail services. In addition, Mr. Merlino serves on the inVentiv Selling Solutions Senior Management Team. With over 21 years of pharmaceutical sales and marketing experience at companies such as Bristol-Myers Squibb and Ciba-Geigy Pharmaceuticals (Novartis), Warren brings a strong skill set in strategic and tactical planning, logistics, marketing, sales, managed care, leadership training and development, and negotiations to PROMOTECH. During the course of his career, Mr. Merlino has had the opportunity to work closely with executives at every level within the health care arena. In his tenure with PROMOTECH, he has led the company through five major company expansions, including the latest, a new 100,000 sq ft. literature distribution center. These changes have enhanced the capabilities available to PROMOTECH clients and positioned this inVentiv division for continued revenue growth. Mr. Merlino earned a B.S. degree in Political Science from Eckerd College in St. Petersburg, Florida as well as an M.B.A. from Emory University in Atlanta, Georgia.

Mr. Chandler and his business partner, Gianfranco Chicco, began CCA in August 1995. Under their leadership, the agency became a top PR consultancy in healthcare, growing from five to 220 people, with revenue exceeding $45 million. Today, CCA has offices in London, Los Angeles, Washington and Paris, and an extensive affiliate network with multiple firms in Asia and Europe. It is also one of the most honored PR firms in the industry, having been named 2007 Agency of the Year by PRWeek and 2007 Healthcare Agency of the Year by The Holmes Report. The agency has appeared consistently on the industry's "Best Agencies to Work For" lists both in the U.S. and Europe.

Mr. Walter was named Chief Executive Officer of inVentiv Health in May 2008, with responsibility for providing the strategic vision for the company, overseeing the four major operating divisions, and developing integrated solutions to meet client needs. Mr. Walter's previous positions at the company included serving as President of inVentiv Health and as President and CEO of the inVentiv Communications division. Mr. Walter also served as Chairman and CEO of inChord Communications, Inc. prior to its acquisition by inVentiv Health in October 2005. Mr. Walter joined inChord (then known as Gerbig, Snell/Weisheimer & Associates) as an Account Manager in 1994. In 1996, he became a Partner and later purchased the company in 2000. Under his direction, inChord became the largest privately-held healthcare communication company in the world, working with 16 of the world's top 20 healthcare companies and serving clients around the world through a global network with offices in 13 countries. Prior to joining inChord, Mr. Walter worked as a financial analyst in New York City for Smith Barney in mergers and acquisitions. He holds a B.S. degree in marketing and finance from Boston College.

Dr. Saxton, 64, has been a director of the Company since December 2006. Dr. Saxton brings over 40 years of experience in pharmaceutical drug development to inVentiv, initially as a clinical investigator and later through more than 25 years with Pfizer Inc. until his retirement in 2001. During his time with Pfizer, Dr. Saxton worked in a variety of positions in both Europe and the USA in the R&D and International commercial divisions.

Mark Jennings is Managing Partner and co-founder of Generation Partners. Mr. Jennings is responsible for the overall strategic direction, capital commitments and management of the firm. Prior to founding Generation, Mr. Jennings spent eight years at Centre Partners, a private investment firm affiliated with Lazard Freres & Co., where he was elected Partner in 1991 at the age of 29. Mr. Jennings began his career at Goldman Sachs & Co. where he advised companies in the areas of financial strategy, public offerings, mergers & acquisitions and leveraged buyouts. Through Generation and predecessor firms, he has invested in more than 50 companies over the past 19 years and has served on the Board of Directors of 22 companies including: Sterling Infosystems - a leading employment information company, Virtual Radiologic Corporation - the largest distributed teleradiology company, Agility Recovery Solutions - a leading disaster recovery company, The Platform for Media - a provider of digital content software solutions, Medvance Institute - an education firm focused on healthcare occupations, Six Flags (NYSE:SIX), Scientific Games (NASDAQ: SGMS) - world leader in the lottery industry, Snyder Communications (NYSE:SNC) - a global direct marketing and advertising company, Muzak - the nation's leading background music provider, inVentiv Health (NASDAQ:VTIV) - a leading provider of sales, marketing and data services to the pharmaceutical and life sciences industries. Mr. Jennings also serves as the Chairman of the Board of Trustees of Post University, a 115 year-old regionally-accredited University and is on the Board of Directors of The Spiritual Cinema Circle, a multi-faith organization dedicated to spiritually-themed films that inspire, heal and transform. He is also involved with the Starlight-Starbright Children's Foundation and Business Executives for National Security. Mr. Jennings earned his MBA from the Harvard Graduate School of Business in 1986 and earned a Bachelor of Science in Mechanical Engineering with Highest Honors from the The University of Texas at Austin in 1984, where he graduated second in his class and received the University's Rhodes Scholarship nomination.